IP Library Granted Patent US 8,317,825
Granted Patent B2
US 8,317,825 · App. 12/419,491 · Granted Nov 27, 2012

Soft tissue conduit device and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,317,825
App. No.
12/419,491
Granted
Nov 27, 2012
Kind
B2
Abstract

A method of conducting biological materials in soft tissue includes inserting an elongated conduit device into the soft tissue and through a defect in the soft tissue, and conducting biological materials along at least one longitudinal channel defined on an outer surface of the conduit device into the soft tissue. The conduit device is externally threaded.

Claims (29)

1. A method of conducting biological materials in meniscal tissue, the method comprising:

providing a conduit device having a first end and a second end and an externally threaded elongated body extending from the first end to the second end along a longitudinal axis of the conduit device, the elongated body having a plurality of external longitudinal channels, each longitudinal channel extending from the first end to the second end along the longitudinal axis, each longitudinal channel being open to an outer surface of the elongated body and having a keyhole-shaped cross-section with a substantially circular portion and a slot-like opening to the outer surface of the elongated body, each slot-like opening being narrower that a width of each circular portion;

implanting the conduit device through the meniscal tissue such that each longitudinal channel extends between a first area of the meniscal tissue having a first vascularity and a second area of the meniscal tissue having a second vascularity different from the first vascularity;

and

delivering via an external cannula biological materials from the first area to the second area along and within the circular portion of each longitudinal channel from the first end toward the second end of the conduit device.

2. The method of claim 1 , further comprising coupling the conduit device to a tissue fixation device.

3. The method of claim 2 , wherein coupling the conduit device to a tissue fixation device includes forming a flexible strand loop between the conduit device and the fixation device.

4. The method of claim 3 , wherein the loop passes through an internal longitudinal bore of the conduit device.

5. The method of claim 3 , wherein the loop passes through one of the longitudinal channels of the conduit device.

6. The method of claim 1 , further comprising tenting the meniscal tissue over the slot-like openings of the longitudinal channels without obstructing the circular portion of the longitudinal channels.

7. The method of claim 1 , further comprising:

delivering biological materials to each longitudinal channel during or after implantation.

8. The method of claim 1 , further comprising:

attaching biological materials to each longitudinal channel before implanting the conduit device.

9. A method of conducting biological materials in meniscal tissue, the method comprising:

providing a conduit device having a first end, a second end, a longitudinal axis and a longitudinal bore between the first end the second end;

passing a suture strand through the longitudinal bore of the conduit device, the conduit device having a plurality of external longitudinal channels not communicating with the longitudinal bore;

coupling the suture strand with a fixation device, the fixation device inserted through a meniscal defect;

returning the suture strand through the longitudinal bore of the conduit device to form a suture loop;

implanting the conduit device through the meniscal defect such that each longitudinal channel extends between a first area having a first vascularity and a second area having a second vascularity different from the first vascularity;

delivering, via an external cannula, biological materials from the first area to the second area along and within the longitudinal channels from the first end toward the second end of each longitudinal channel; and

securing the suture loop with a knot.

10. The method of claim 9 , wherein delivering biological materials from the first area to the second area through the longitudinal channels comprises delivering biological materials through a substantially circular portion of a cross-section of each of the longitudinal channels, the circular portion leading to a slot narrower than the circular portion and extending to an outer surface of the conduit device.

11. The method of claim 10 , further comprising tenting the meniscal tissue over the slots of the cross-sections of the corresponding longitudinal channels without obstructing the circular portion of the longitudinal channels.

12. The method of claim 9 , wherein delivering biological materials from the first area to the second area through the longitudinal channels comprises delivering biological materials through a substantially V-shaped cross-section of each of the longitudinal channels.

13. The method of claim 9 , wherein implanting the conduit device through the meniscal defect comprises positioning the conduit device to span a meniscal tear.

14. The method of claim 13 , further comprising

passing the suture strand through a second fixation device and a second conduit device; and

closing the meniscal tear.

Assignments (2)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241 Recorded Nov 23, 2015
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC.; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTR-OBIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
Reel/Frame 037155/0082 →
SECURITY AGREEMENT Recorded Nov 12, 2009
From: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTRO-BIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT FOR THE SECURED PARTIES
Reel/Frame 023505/0241 →